In August 2020, the GNEN/GL parliamentary group in the European Parliament commissioned OTMeds to produce an independent report on the opportunities for pharmaceutical relocation in Europe or in the Member States.

The Observatory of Transparency in Medicines Policies (OTMeds) publishes this Tuesday, March 1 a report on the challenges of the relocation of pharmaceutical production in Europe, analyzed on the basis… Lire la suite Addressing medicines shortages & regulating prices: OTMeds publishes its report on pharmaceutical production in Europe

The Observatory for Transparency in Medicines Policies (OTMeds) calls on the 2022 presidential election candidates to position themselves in favor of the « patent/TRIPS waiver » to allow access to COVID-19 vaccines… Lire la suite French presidential elections: candidates must support the patent waiver on vaccines

Here we go again:Chaos rules global response to omicron variant Almost two years into the pandemic, finger-pointing, lack of coordination, sparse information and fear are once again influencing policy. Pauline… Lire la suite The New York Times

We are publishing here, the English translation, of the Op-ed we co-signed. This op-ed was initially published in the edition of Le Monde dated of Tuesday, January 19, 2021 and… Lire la suite Op-Ed in Le Monde: Against Covid-19, we must ensure access to vaccines in Africa

Not fast enough: How to speed up rollout of Covid-19 vaccine? If 2020 was the year of the pandemic, may 2021 be the year we won the race to save… Lire la suite France 24

A watered-down amendment on transparency was adopted. If this amendment is historic, as it constitutes a first step in the implementation by France of the resolution on transparency adopted by… Lire la suite A historic, but also insufficient transparency amendment adopted by French Parliament

On the occasion of the centenary of insulin, the NGO Santé Diabète and the Observatory for Transparency in Drug Policies (OTMeds) announce a partnership around access to vital drugs and… Lire la suite OTMeds & SantéDiabète to join forces for access to insulin & better health policies

Through a Decree, Italy implements a part of the transparency resolution. While transparency is moving forward in Italy, while Members of German Parliament are working on a motion in the… Lire la suite Pioneer, Italy implements a part of the WHO transparency resolution on medicines

The Global Health Centre and Observatoire de la transparence dans les politiques du médicament (OTMeds) are delighted to invite you to the event « Transparency and Access to Medicines: One Year… Lire la suite Transparency and Access to Medicines: One Year After the WHA Resolution

The Transparency in medicines policies Awards are attributed in recognition to actions that contributed to the implementation of transparency in medicines and health products policies, in particular those linked to… Lire la suite The Transparency Observatory Attributes Two Awards For 2019

This Op-Ed was written by the NGO Santé Diabète and us. It was published in the sciences columns of Le Monde (2020/01/08) : « How dare it be claimed that there… Lire la suite Novartis scandal : the product of a system encouraged by the lack of public policy

Public hospital, social security, healthcare access for migrants, pensions: l’Observatoire de la transparence dans les politiques du médicament calls on ending all austerity policies, in particular those related to health,… Lire la suite Against austerity in health policies and for transparency

The Observatory was invited to speak, on September 26, 2019, at the French National Assembly (Lower house) by the Member of Parliament (MP) François Ruffin (Somme Deputy, La France Insoumise)… Lire la suite The Observatory at the French Parliament

The “national transparency check-list on medicines and health products” was developed by the Observatoire de la transparence dans les politiques du medicaments in August 2019…